We found variations in adverse events across different genders, age groups, indications, and treatment durations
Boxed warnings: What to know
Just as combining different treatments is common for managing these conditions, it might seem logical to combine weight-loss medications for better results
Understanding the Bigger Picture: Stalls, Fluctuations, and Success on GLP-1 The path to weight loss isnt always a straight line
Effect of l -carnitine supplementation on children and adolescents with nonalcoholic fatty liver disease (NAFLD): A randomized, triple-blind, placebo-controlled clinical trial
The company's antibody-drug conjugate and bispecific antibody pipeline includes peptide-linker components, and its oncology focus positions it strongly in the Oncology Peptide Therapy segment (11.79% CAGR through 2031)